gemcitabine has been researched along with plastochromanol 8 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, BB; Deorukhkar, A; Dey, S; Diagaradjane, P; Gelovani, JG; Guha, S; Koca, C; Krishnan, S; Kunnumakkara, AB; Ravindran, J; Sung, B; Tong, Z; Yadav, VR | 1 |
Abu-Fayyad, A; Nazzal, S | 1 |
2 other study(ies) available for gemcitabine and plastochromanol 8
Article | Year |
---|---|
{Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Blotting, Western; Cell Proliferation; Chromans; Cyclooxygenase 2; Deoxycytidine; Drug Resistance, Neoplasm; Gemcitabine; Humans; Inflammation; Inflammation Mediators; Male; Matrix Metalloproteinase 9; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; RNA, Messenger; Tumor Cells, Cultured; Vitamin E; Xenograft Model Antitumor Assays | 2010 |
Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chromans; Deamination; Deoxycytidine; Gemcitabine; Humans; Nanoparticles; Tocotrienols; Vitamin E | 2017 |